Literature DB >> 24142852

Update on herpes virus infections of the nervous system.

Israel Steiner1, Felix Benninger.   

Abstract

Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) are human neurotropic viruses that establish latent infection in dorsal root ganglia (DRG) for the entire life of the host. From the DRG they can reactivate to cause human morbidity and mortality. Although they vary, in part, in the clinical disorders they cause, and in their molecular structure, they share several features that govern the biology of their infection of the human nervous system. HSV-1 is the causative agent of encephalitis, corneal blindness, and several peripheral nervous system disorders; HSV-2 is responsible for meningoencephalitis in neonates and meningitis in adults. The biology of their ability to establish latency, maintain it for the entire life of the host, reactivate, and cause primary and recurrent disease is being studied in animal models and in humans. This review covers recent advances in understanding the biology and pathogenesis of HSV-related disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142852     DOI: 10.1007/s11910-013-0414-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  89 in total

1.  Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures.

Authors:  Ying-Hsiu Su; Michael J Moxley; Alan K Ng; Judy Lin; Robert Jordan; Nigel W Fraser; Timothy M Block
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

2.  IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression.

Authors:  Jorma Tissari; Jukka Sirén; Seppo Meri; Ilkka Julkunen; Sampsa Matikainen
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

Review 3.  Molecular anatomy of viral persistence.

Authors:  M B Oldstone
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Viral persistence in neurons explained by lack of major histocompatibility class I expression.

Authors:  E Joly; L Mucke; M B Oldstone
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

Review 5.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

6.  Efficacy results of a trial of a herpes simplex vaccine.

Authors:  Robert B Belshe; Peter A Leone; David I Bernstein; Anna Wald; Myron J Levin; Jack T Stapleton; Iris Gorfinkel; Rhoda L Ashley Morrow; Marian G Ewell; Abbie Stokes-Riner; Gary Dubin; Thomas C Heineman; Joann M Schulte; Carolyn D Deal
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

7.  Herpes simplex encephalitis. Clinical Assessment.

Authors:  R J Whitley; S J Soong; C Linneman; C Liu; G Pazin; C A Alford
Journal:  JAMA       Date:  1982-01-15       Impact factor: 56.272

Review 8.  Management of herpes simplex virus stromal keratitis: an evidence-based review.

Authors:  Jared E Knickelbein; Robert L Hendricks; Puwat Charukamnoetkanok
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

Review 9.  Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.

Authors:  Scott H James; David W Kimberlin; Richard J Whitley
Journal:  Antiviral Res       Date:  2009-05-04       Impact factor: 5.970

Review 10.  Herpes simplex virus infects most cell types in vitro: clues to its success.

Authors:  Ghadah A Karasneh; Deepak Shukla
Journal:  Virol J       Date:  2011-10-26       Impact factor: 4.099

View more
  57 in total

1.  Battling the spread: Herpes simplex virus and encephalitis.

Authors:  Christina M Slifer; Stephen R Jennings
Journal:  Immunol Cell Biol       Date:  2015-08-11       Impact factor: 5.126

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 3.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

4.  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.

Authors:  Craig B Wilen; Cynthia L Monaco; Joan Hoppe-Bauer; Ronald Jackups; Robert C Bucelli; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

5.  Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.

Authors:  Lihong Li; Zhuoran Li; Erlin Wang; Rui Yang; Yu Xiao; Hongbo Han; Fengchao Lang; Xin Li; Yujie Xia; Feng Gao; Qihan Li; Nigel W Fraser; Jumin Zhou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

6.  Rapid and direct detection of herpes simplex virus in cerebrospinal fluid by use of a commercial real-time PCR assay.

Authors:  Matthew J Binnicker; Mark J Espy; Cole L Irish
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

7.  Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense.

Authors:  Xing Wang; Yun Li; Shan Liu; Xiaoliang Yu; Lin Li; Cuilin Shi; Wenhui He; Jun Li; Lei Xu; Zhilin Hu; Lu Yu; Zhongxu Yang; Qin Chen; Lin Ge; Zili Zhang; Biqi Zhou; Xuejun Jiang; She Chen; Sudan He
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

Review 8.  Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department.

Authors:  Maia Dorsett; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2016-11       Impact factor: 2.264

9.  An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.

Authors:  Olus Uyar; Nataly Laflamme; Jocelyne Piret; Marie-Christine Venable; Julie Carbonneau; Karima Zarrouk; Serge Rivest; Guy Boivin
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 10.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.